BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29549391)

  • 1. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
    Jackson A; Papke RL; Damaj MI
    Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test.
    Jackson A; Alkhlaif Y; Papke RL; Brunzell DH; Damaj MI
    Psychopharmacology (Berl); 2019 Dec; 236(12):3593-3599. PubMed ID: 31302720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
    Stoker AK; Olivier B; Markou A
    Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit.
    Salas R; Main A; Gangitano D; De Biasi M
    Neuropharmacology; 2007 Dec; 53(7):863-9. PubMed ID: 17920082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
    Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.
    Donvito G; Bagdas D; Toma W; Rahimpour E; Jackson A; Meade JA; AlSharari S; Kulkarni AR; Ivy Carroll F; Lichtman AH; Papke RL; Thakur GA; Imad Damaj M
    Exp Neurol; 2017 Sep; 295():194-201. PubMed ID: 28606623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the alpha-7 nicotinic acetylcholine receptor (α7 nAchR) reverses referred mechanical hyperalgesia induced by colonic inflammation in mice.
    Costa R; Motta EM; Manjavachi MN; Cola M; Calixto JB
    Neuropharmacology; 2012 Oct; 63(5):798-805. PubMed ID: 22722030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.
    Kwilasz AJ; Harris LS; Vann RE
    Pharmacol Biochem Behav; 2009 Nov; 94(1):114-8. PubMed ID: 19660491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.
    Freitas K; Negus SS; Carroll FI; Damaj MI
    Br J Pharmacol; 2013 Jun; 169(3):567-79. PubMed ID: 23004024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
    Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
    Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive control deficits during mecamylamine-precipitated withdrawal in mice: Possible links to frontostriatal BDNF imbalance.
    Parikh V; Cole RD; Patel PJ; Poole RL; Gould TJ
    Neurobiol Learn Mem; 2016 Feb; 128():110-6. PubMed ID: 26775017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7 Nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine.
    Ishida S; Kawasaki Y; Araki H; Asanuma M; Matsunaga H; Sendo T; Kawasaki H; Gomita Y; Kitamura Y
    Psychopharmacology (Berl); 2011 Apr; 214(4):923-31. PubMed ID: 21125398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning.
    Milienne-Petiot M; Higa KK; Grim A; Deben D; Groenink L; Twamley EW; Geyer MA; Young JW
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1217-1231. PubMed ID: 30213668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.
    Jackson KJ; Martin BR; Changeux JP; Damaj MI
    J Pharmacol Exp Ther; 2008 Apr; 325(1):302-12. PubMed ID: 18184829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
    Harris AC; Manbeck KE; Schmidt CE; Shelley D
    Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal α7 nACh receptors in mice.
    Keyworth H; Georgiou P; Zanos P; Rueda AV; Chen Y; Kitchen I; Camarini R; Cropley M; Bailey A
    Br J Pharmacol; 2018 Jun; 175(11):1928-1943. PubMed ID: 29266170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco smoke exposure induces nicotine dependence in rats.
    Small E; Shah HP; Davenport JJ; Geier JE; Yavarovich KR; Yamada H; Sabarinath SN; Derendorf H; Pauly JR; Gold MS; Bruijnzeel AW
    Psychopharmacology (Berl); 2010 Jan; 208(1):143-58. PubMed ID: 19936715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
    Singh TG; Rehni AK; Arora SK
    Behav Pharmacol; 2013 Dec; 24(8):668-77. PubMed ID: 24196026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.